|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.17 CAD | -5.56% |
|
0.00% | -15.00% |
| Apr. 10 | Telo Genomics Receives Accreditation from College of American Pathologists | MT |
| Apr. 10 | Telo Genomics Corp. Receives Accreditation from College of American Pathologists | CI |
Telo Genomics Corp. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported net loss was CAD 0.672549 million compared to CAD 0.615805 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.00% | 8.86M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
TELO GENOMICS CORP. 
